Literature DB >> 18685254

Genetic association between SORL1 polymorphisms and Alzheimer's disease in a Japanese population.

Nobuto Shibata1, Tohru Ohnuma, Hajime Baba, Shinji Higashi, Kenya Nishioka, Heii Arai.   

Abstract

BACKGROUND/AIMS: It has recently been shown that the neuronal sortilin-related receptor (SORL1) plays an important role in the pathogenesis of Alzheimer's disease (AD).
METHODS: To investigate whether variations around the SORL1 gene are associated with AD, 7 single-nucleotide polymorphisms (SNPs) were genotyped using TaqMan technology with 180 AD patients and 130 age-matched controls.
RESULTS: Our results confirmed the strong linkage disequilibrium among the 7 SNPs studied. However, our study failed to detect any association between the SNPs and AD. We could not confirm any synergetic interaction between the SNPs and apolipoprotein E in our AD patients either.
CONCLUSION: Further genetic studies are needed to clarify the relationship between the SORL1 gene and AD. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685254     DOI: 10.1159/000149821

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  18 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Authors:  Ramón Cacabelos; Rocío Martínez; Lucía Fernández-Novoa; Juan C Carril; Valter Lombardi; Iván Carrera; Lola Corzo; Iván Tellado; Jerzy Leszek; Adam McKay; Masatoshi Takeda
Journal:  Int J Alzheimers Dis       Date:  2012-03-14

Review 3.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 4.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

5.  Possible association between SORL1 and Alzheimer disease? Reanalysing the data of Shibata et al.

Authors:  Joseph H Lee; Nobuto Shibata; Rong Cheng; Richard Mayeux
Journal:  Dement Geriatr Cogn Disord       Date:  2008-11-04       Impact factor: 2.959

6.  Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.

Authors:  Ziran Wang; Hongyan Lei; Mei Zheng; Yuxin Li; Yansen Cui; Fang Hao
Journal:  Mol Neurobiol       Date:  2015-11-27       Impact factor: 5.590

Review 7.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

Review 8.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 9.  Endophenotypes in normal brain morphology and Alzheimer's disease: a review.

Authors:  C Reitz; R Mayeux
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

10.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.

Authors:  Gary W Beecham; Eden R Martin; Yi-Ju Li; Michael A Slifer; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.